Vanda Pharmaceuticals Inc. (VNDA) Insider Trading

Last 12 months

Insiders sold $2.82M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. President and CEO Mihael Hristos Polymeropoulos sold $1.28M on Mar 2, 5.5% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2025.

Net open-market

−$2.82M

0 buys · 6 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 6

executives and directors

Last open-market buy

Aug 2025

Aug 7, 2025

Get an email when VNDA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Mar 2	Kevin Patrick Moran SVP, CFO & Treasurer	SoldNo plan	42,442	$8.27	$351k	9.3%	Form 4
Mar 2	Joakim Wijkstrom SVP, Chief Marketing Officer	SoldNo plan	30,800	$8.27	$255k	8.5%	Form 4
Mar 2	Timothy Williams SVP & General Counsel	SoldNo plan	42,434	$8.27	$351k	10%	Form 4
Mar 2	Gunther Birznieks SVP, Business Development	SoldNo plan	42,431	$8.27	$351k	7.9%	Form 4
Mar 2	Mihael Hristos Polymeropoulos President and CEO	SoldNo plan	156,235	$8.17	$1.28M	5.5%	Form 4
Feb 23	Tage Honore Director	SoldNo plan	30,000	$8.03	$241k	24%	Form 4
Aug 7, 2025	Mihael Hristos Polymeropoulos President and CEO	Bought	10,000	$4.15	$42k	0.4%	Form 4
Jun 13, 2025	Stephen Ray Mitchell Director	SoldNo plan	7,000	$4.59	$32k	6.7%	Form 4
May 21, 2025	Mihael Hristos Polymeropoulos President and CEO	Bought 2 parts	10,000	$4.40 average	$44k	0.4%	Form 4
May 16, 2025	Mihael Hristos Polymeropoulos President and CEO	Bought	20,000	$4.22	$84k	0.9%	Form 4
Mar 6, 2025	Mihael Hristos Polymeropoulos President and CEO	Bought 2 parts	10,000	$5.02 average	$50k	0.4%	Form 4
Mar 5, 2025	Mihael Hristos Polymeropoulos President and CEO	Bought 2 parts	10,000	$5.02 average	$50k	0.4%	Form 4
Mar 3, 2025	Mihael Hristos Polymeropoulos President and CEO	Bought	10,000	$4.71	$47k	0.4%	Form 4
Feb 28, 2025	Mihael Hristos Polymeropoulos President and CEO	Bought	10,000	$4.76	$48k	0.4%	Form 4
Feb 27, 2025	Mihael Hristos Polymeropoulos President and CEO	Bought	10,000	$4.76	$48k	0.4%	Form 4
Feb 26, 2025	Mihael Hristos Polymeropoulos President and CEO	Bought 2 parts	10,000	$4.77 average	$48k	0.4%	Form 4
Feb 25, 2025	Mihael Hristos Polymeropoulos President and CEO	Bought	10,000	$4.46	$45k	0.4%	Form 4
Feb 21, 2025	Kevin Patrick Moran SVP, CFO & Treasurer	Bought	2,000	$4.39	$9k	0.6%	Form 4
Nov 14, 2024	Stephen Ray Mitchell Director	SoldNo plan	5,000	$5.17	$26k	10%	Form 4

Mar 2No plan
Kevin Patrick Moran
SVP, CFO & Treasurer · sold 42,442 at $8.27
$351k
9.3% of stake
Mar 2No plan
Joakim Wijkstrom
SVP, Chief Marketing Officer · sold 30,800 at $8.27
$255k
8.5% of stake
Mar 2No plan
Timothy Williams
SVP & General Counsel · sold 42,434 at $8.27
$351k
10% of stake
Mar 2No plan
Gunther Birznieks
SVP, Business Development · sold 42,431 at $8.27
$351k
7.9% of stake
Mar 2No plan
Mihael Hristos Polymeropoulos
President and CEO · sold 156,235 at $8.17
$1.28M
5.5% of stake
Feb 23No plan
Tage Honore
Director · sold 30,000 at $8.03
$241k
24% of stake
Aug 7, 2025
Mihael Hristos Polymeropoulos
President and CEO · bought 10,000 at $4.15
$42k
0.4% of stake
Jun 13, 2025No plan
Stephen Ray Mitchell
Director · sold 7,000 at $4.59
$32k
6.7% of stake
May 21, 2025
Mihael Hristos Polymeropoulos
President and CEO · bought 10,000 at avg $4.40
$44k
0.4% of stake
May 16, 2025
Mihael Hristos Polymeropoulos
President and CEO · bought 20,000 at $4.22
$84k
0.9% of stake
Mar 6, 2025
Mihael Hristos Polymeropoulos
President and CEO · bought 10,000 at avg $5.02
$50k
0.4% of stake
Mar 5, 2025
Mihael Hristos Polymeropoulos
President and CEO · bought 10,000 at avg $5.02
$50k
0.4% of stake
Mar 3, 2025
Mihael Hristos Polymeropoulos
President and CEO · bought 10,000 at $4.71
$47k
0.4% of stake
Feb 28, 2025
Mihael Hristos Polymeropoulos
President and CEO · bought 10,000 at $4.76
$48k
0.4% of stake
Feb 27, 2025
Mihael Hristos Polymeropoulos
President and CEO · bought 10,000 at $4.76
$48k
0.4% of stake
Feb 26, 2025
Mihael Hristos Polymeropoulos
President and CEO · bought 10,000 at avg $4.77
$48k
0.4% of stake
Feb 25, 2025
Mihael Hristos Polymeropoulos
President and CEO · bought 10,000 at $4.46
$45k
0.4% of stake
Feb 21, 2025
Kevin Patrick Moran
SVP, CFO & Treasurer · bought 2,000 at $4.39
$9k
0.6% of stake
Nov 14, 2024No plan
Stephen Ray Mitchell
Director · sold 5,000 at $5.17
$26k
10% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch VNDA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Pharmaceutical Preparations

IDYAIdeaya Biosciences Inc.

AKBAAkebia Therapeutics Inc.

MRVIMaravai Lifesciences Holdings Inc.

PBYIPuma Biotechnology Inc.

ANABAnaptysBio Inc.

RCUSArcus Biosciences Inc.

LFVNLifeVantage Corporation

PHATPhathom Pharmaceuticals Inc.

Spot a number that looks wrong? Check it in VNDA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing VNDA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.